Morning Briefing
Summaries of health policy coverage from major news organizations
Leahy Introduces Generic Drug Label Legislation
The measure, which was introduced in the Senate and has a House companion, would permit generic drug companies to update safety information about the drugs they manufacture, enabling patients to sue the companies for failing to issue warnings about risks. It aims to address a gap in the law that allows people to sue brand-name drug makers for insufficient warnings, but not generics manufacturers.
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
